David C. W. Lau, MD, PhD, FRCPC - Endocrinology and Metabolism
Dr. David Lau reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Lau is a practicing endocrinologist who specializes in, , and lipid . He is an active researcher, educator, and clinician, and he has published over 100 scientific papers. Dr. Lau is also involved in giving public lectures and forums on , , and . He spearheaded the evidence-based Obesity Canada clinical practice guidelines for the management and prevention of in adults and children. He has also served as an expert panel member on the WHO-International Obesity Task Force and the 1998, 2003, and 2007 Canadian Diabetes Association Clinical Practice Guidelines for Body Weight Classification. Dr. Lau is a Professor of Medicine, Biochemistry, and Molecular Biology, and Chair of the Diabetes and Endocrine Research Group at the University of Calgary.
Education and Training
MD: University of Toronto, Toronto, ON
PhD: University of Toronto, Toronto, ON
Internship and Residency in Internal Medicine and Endocrinology: Harvard Medical School, Boston, MA
Residency and Fellowship in Internal Medicine and Endocrinology: University of Toronto, Toronto, ON
American Board of Internal Medicine
Royal College of Physicians and Surgeons of Canada
University of Calgary, Calgary, AL:
- Professor, Departments of Medicine, Biochemistry, and Molecular Biology
- Adjunct Professor, Faculty of Kinesiology
The final approval of Healthwise content is always made by a clinician with no financial conflicts.
Research grant support and compensation for consulting received from:
- Abbott Laboratories.
- Bristol Myers Squibb.
- Eli Lilly Pharmaceuticals.
- Janssen Inc.
- Merck and Co.
- Novo Nordisk.
Current as of:
June 27, 2014